Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Monocrotaline

Related Products

Hot Products

Name

Monocrotaline

EINECS 628-506-2
CAS No. 315-22-0 Density 1.35 g/cm3
PSA 96.30000 LogP -0.45470
Solubility 11.86g/L(temperature not stated) Melting Point 204 °C
Formula C16H23NO6 Boiling Point 537.3 °C at 760 mmHg
Molecular Weight 325.362 Flash Point 278.7 °C
Transport Information UN 1544 6.1/PG 3 Appearance white to light tan powder
Safety 36/37/39-45 Risk Codes 25-40
Molecular Structure Molecular Structure of 315-22-0 (MONOCROTALINE) Hazard Symbols ToxicT
Synonyms

20-Norcrotalanan-11,15-dione,14,19-dihydro-12,13-dihydroxy-, (13a,14a)-;Monocrotaline (6CI,7CI,8CI);(-)-Monocrotaline;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,[3R-(3R*,4R*,5R*,13aR*,13bR*)]-;Monocrotalin;NSC 28693;Monocrotaline;(13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione;Crotaline;

Article Data 5

Monocrotaline Synthetic route

110121-56-7, 121719-98-0, 121720-00-1

monocrotaline methylene acetal

315-22-0

monocrotaline

Conditions
ConditionsYield
With trityl tetrafluoroborate In dichloromethane for 48h; Heating;86%
With hydrogenchloride; trityl tetrafluoroborate 1.) CH2Cl2, reflux, 48 h, 2.) room temperature, 17.5 h; Yield given. Multistep reaction;
Conditions
ConditionsYield
With hydrogenchloride In ethylene glycol at 110℃; for 2h;75%
35337-98-5

Monocrotaline N-oxide

315-22-0

monocrotaline

Conditions
ConditionsYield
With intestinal gut bacteria in a human fecal suspension at 37℃; for 5h; Enzymatic reaction;38%
24583-56-0

grahamine

315-22-0

monocrotaline

Conditions
ConditionsYield
With hydrogenchloride
109391-24-4, 121787-06-2

(2R,3R,4R)-2,3,4-trimethyl-2,3-methylenedioxypentanedioic anhydride

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
2: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
2: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
109494-78-2, 121787-04-0

(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Ac2O / CH2Cl2 / 3.5 h / Heating
2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
3: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 4 steps
1: Ac2O / CH2Cl2 / 3.5 h / Heating
2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
3: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
121719-94-6

(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentene

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
5: Ac2O / CH2Cl2 / 3.5 h / Heating
6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
7: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 8 steps
1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
5: Ac2O / CH2Cl2 / 3.5 h / Heating
6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
7: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
146070-68-0

(R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (4S,5R)-4,5-dimethyl-5-((R)-1-methyl-2-oxo-ethyl)-[1,3]dioxolan-4-ylmethyl ester

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
3: Ac2O / CH2Cl2 / 3.5 h / Heating
4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
5: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
3: Ac2O / CH2Cl2 / 3.5 h / Heating
4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
5: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
121719-96-8

(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxypentanoic acid

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
2: Ac2O / CH2Cl2 / 3.5 h / Heating
3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
4: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 5 steps
1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
2: Ac2O / CH2Cl2 / 3.5 h / Heating
3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
4: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
121719-93-5, 121787-08-4

(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentanol

315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 83 percent / POCl3, pyridine / 17 h / 85 °C
2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
6: Ac2O / CH2Cl2 / 3.5 h / Heating
7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
8: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 9 steps
1: 83 percent / POCl3, pyridine / 17 h / 85 °C
2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
6: Ac2O / CH2Cl2 / 3.5 h / Heating
7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
8: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme

Monocrotaline Consensus Reports

IARC Cancer Review: Group 2B IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 ,1976,p. 291.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.

Monocrotaline Specification

The systematic name of Monocrotaline is (3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione. With the CAS registry number 315-22-0, it is also named as (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione. The product's category is Miscellaneous Natural Products. Besides, it is white to light tan powder, which should be stored in sealed and dry place at 2-8 °C. This chemical is anticarcinoma drug that is used for biochemical research. In addition, its molecular formula is C16H23NO6 and molecular weight is 325.35692.

Physical properties about Monocrotaline are: (1)ACD/LogP: -4.137; (2)ACD/LogD (pH 5.5): -4.76; (3)ACD/LogD (pH 7.4): -4.15; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 7; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 2; (11)Index of Refraction: 1.586; (12)Molar Refractivity: 80.3 cm3; (13)Molar Volume: 239.352 cm3; (14)Polarizability: 31.834 10-24cm3; (15)Surface Tension: 59.2760009765625 dyne/cm; (16)Density: 1.359 g/cm3; (17)Flash Point: 278.731 °C; (18)Enthalpy of Vaporization: 93.63 kJ/mol; (19)Boiling Point: 537.27 °C at 760 mmHg

When you are using this chemical, please be cautious about it as the following: it is toxic if swallowed. Limited evidence of a carcinogenic effect. You should wear suitable protective clothing, gloves and eye/face protection. Moreover, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

You can still convert the following datas into molecular structure:
(1)InChI=1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1;
(2)InChIKey=QVCMHGGNRFRMAD-XFGHUUIASA-N;
(3)Smiles[C@@H]12[C@H]3CCN1CC=C2COC(=O)[C@]([C@]([C@H](C(=O)O3)C)(C)O)(C)O

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mammal (species unspecified) LDLo unreported 60mg/kg (60mg/kg)   Pharmacological Reviews. Vol. 22, Pg. 429, 1970.
mouse LD50 intraperitoneal 259mg/kg (259mg/kg)   Toxicology and Applied Pharmacology. Vol. 59, Pg. 424, 1981.
mouse LD50 intravenous 261mg/kg (261mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 75, Pg. 78, 1942.
rat LD50 intravenous 92mg/kg (92mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 83, Pg. 265, 1945.
rat LD50 oral 66mg/kg (66mg/kg) LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" Toxicology and Applied Pharmacology. Vol. 18, Pg. 387, 1971.
rat LD50 subcutaneous 60mg/kg (60mg/kg)   Toxicology and Applied Pharmacology. Vol. 23, Pg. 470, 1972.
rat LD50 unreported 60mg/kg (60mg/kg)   Cancer Research. Vol. 28, Pg. 2237, 1968.
rat LDLo intraperitoneal 130mg/kg (130mg/kg) LIVER: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Chemico-Biological Interactions. Vol. 12, Pg. 299, 1976.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 315-22-0